Citius Oncology (CTOR) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Citius Oncology (CTOR) over the past year, losing 34.4% versus a loss of 53.0%. Quantum Cyber N.V. is the larger company by market cap ($86.6 million vs $85.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | QUCY |
|---|---|---|
| Share price | $0.8126 | $1.03 |
| Market cap | $85.94M | $86.59M |
| 1-day change | -3.24% | -23.70% |
| YTD return | -18.74% | -8.04% |
| 1-year return | -53.03% | -34.39% |
| EPS (TTM) | $-0.48 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $4.93 |
| 52-week low | $0.491 | $0.30 |
| Distance from 52-week high | -63.88% | -79.11% |
| Analyst consensus | none | none |
| Avg. price target upside | +392.25% | +773.79% |
| Average volume | 100.94K | 689.09K |
| Shares outstanding | 105.76M | 84.07M |
| Employees | — | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QUCY has outperformed CTOR by 18.6 percentage points over the past year.
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
CTOR vs QUCY FAQ
Which is bigger, Citius Oncology or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $86.59M compared with $85.94M for Citius Oncology (CTOR).
Which stock has performed better over the past year, CTOR or QUCY?
QUCY returned -34.39% over the past 12 months, compared with -53.03% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.